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Skeletal development and invasion by tumor cells
depends on proteolysis of collagen by the pericellu-
lar metalloproteinase MT1-MMP. Its hemopexin-like
(HPX) domain binds to collagen substrates to facili-
tate their digestion. Spin labeling and paramagnetic
nuclear magnetic resonance (NMR) detection have
revealed how the HPX domain docks to collagen I–
derived triple helix. Mutations impairing triple-helical
peptidase activity corroborate the interface. Satu-
ration transfer difference NMR suggests rotational
averaging around the longitudinal axis of the triple-
helical peptide. Part of the interface emerges as
unique and potentially targetable for selective inhibi-
tion. The triple helix crosses the junction of blades I
and II at a 45 angle to the symmetry axis of the
HPX domain, placing the scissile GlyIle bond near
the HPX domain and shifted25 A˚ fromMMP-1 com-
plexes. This raises the question of the MT1-MMP
catalytic domain folding over the triple helix during
catalysis, a possibility accommodated by the flexi-
bility between domains suggested by atomic force
microscopy images.
INTRODUCTION
Collagen degradation bymembrane type 1 (MT1) matrix metallo-
proteinase (MMP) or MMP-14 contributes to several important
pathophysiological processes. Without MT1-MMP, develop-
ment of the skeleton is deranged (Holmbeck et al., 1999), and os-
teocytes fail to digest collagen (Holmbeck et al., 2005). Invasion
of 3D collagen matrices by endothelial cells, tumor cells, and
rheumatoid synovial fibroblasts is conferred by MT1-MMP at
their leading edges (Galvez et al., 2001; Miller et al., 2009; Sabeh
et al., 2004; Stratman et al., 2009). Formation of new blood ves-
sels requires MT1-MMP (Chun et al., 2004) and endothelial cells
form vascular guidance tunnels via MT1-MMP activity (Stratman
et al., 2009). Tumor cells enmeshed in 3D collagen are restricted
to spheroid morphology without growing or dividing, whereasStructure 23, 25MT1-MMP expression frees the tumor cells to grow and prolifer-
ate (Hotary et al., 2003). After myocardial infarction, increased
cardiac expression of MT1-MMP decreases both left ventricular
function and survival of mice (Zavadzkas et al., 2011). MT1-MMP
is also overexpressed in atherosclerotic plaques, possibly desta-
bilizing the plaques (Johnson et al., 2008) by degrading collagen
(Schneider et al., 2008).
In invasive cell pseudopodia, the collagenase activity of MT1-
MMP depends upon interacting with palladin, which connects it
to the actin cytoskeleton (von Nandelstadh et al., 2014), and
upon dynamic homodimerization regulated by the reorganization
of the actin cytoskeleton by Rho guanosine triphosphatases
(Itoh et al., 2011). This self-association, which can occur at the
leading but not trailing cell surfaces, appears to depend on the
hemopexin-like (HPX) (Itoh et al., 2001), transmembrane, and
cytoplasmic domains (Itoh et al., 2008; Lehti et al., 2002;Rozanov
et al., 2001). Collagen degradation was disrupted efficiently by
overexpression of MT1-MMP without its catalytic domain and
less efficientlywhen the transmembrane anchorwasalsodeleted
(Itoh et al., 2006; Miller et al., 2009). These truncations disrupted
assembly of MT1-MMP into a collagenolytic form in the plasma
membrane. This was attributed to defective homodimerization
(Itoh et al., 2006), but the truncations may also have disturbed
other interactions that facilitate its collagenase activity, such as
its association with cell adhesion complexes that contain b1-
integrins (Woskowicz et al., 2013) and association with the cyto-
skeleton via palladin (von Nandelstadh et al., 2014). The soluble
ectodomain of MT1-MMP is monomeric and very active in
collagen degradation, propelling it in one direction along the
collagen fibril, analogous to MMP-1 (Collier et al., 2011).
The soluble ectodomain of MT1-MMP comprises the catalytic
and HPX domains but not the C-terminal transmembrane an-
chor. The ectodomain digests fibrillar collagens I, II, and III into
the 3/4 and 1/4 fragments characteristic of collagenases (Ohuchi
et al., 1997). The bonds hydrolyzed are Gly775-Ile776 of a1(I) and
Gly775-Leu776 and Gly781-Ile782 of a2(I) chains (Ohuchi et al.,
1997). The HPX domain of MT1-MMP binds collagen (Tam et al.,
2004), but not in a cellular assay (Itoh et al., 2006). Effects of de-
leting the HPX domain from MT1-MMP included elimination of
collagen invasion by cells (Wang et al., 2004), diminution of col-
lagenolysis at the cell surface, retention of half of collagen-inva-
sive activity of cells (Li et al., 2008), and prevention of tumor
growth in vivo (Remacle et al., 2012). Single-chain antibodies7–269, February 3, 2015 ª2015 Elsevier Ltd All rights reserved 257
Figure 1. Perturbations of NMR Spectra Suggest the THP Binding Site on the HPX Domain of MT1-MMP
(A) The crystal structure of the HPX domain (PDB ID 3c7x) (Tochowicz et al., 2011) colors blades I–IV pink, green, light blue, and yellow, respectively. THP-induced
perturbations of NMR peaks are colored red where shifted, blue where broadened, and purple for both.
(B) NMRpeaks in the 15N TROSY spectrum of the HPX domain affected by addition of a1(I)772-786 THP are labeled. The spectral contours of the free state are red
and the bound state blue (1.5-fold molar excess of THP [pH 5], 25C). The box encloses arginine side chain NHε peaks, which are assigned in Figure S1D.
(C) THP-induced chemical shift perturbations (upper panel) and NMR line broadening (lower panel) are plotted versus sequence. The chemical shift perturbation
is quantified as DuHN = (DuH
2 + (DuN/5)
2)1/2, where DuH and DuN are the peak shifts in ppm in the
1H and 15N dimensions. The NMR line broadening is quantified
as 1  ITHP/I0, where ITHP and I0 are the peak heights with and without one equivalent of THP.against the HPX domain of MT1-MMP inhibit collagen degrada-
tion and cell invasion and sprouting through type I collagen, sug-
gesting the therapeutic potential of this approach (Basu et al.,
2012).
The HPX domain has the fold of a four-bladed b-propeller
(Tochowicz et al., 2011) (Figure 1A) of 23 kDa, with sequence
features repeated among the blades. Its migration with apparent
molecular weight (MW) of 32 to 40 kDa by gel permeation was
interpreted as dimerization in solution (Itoh et al., 2001, 2006).
This view, however, was revised by quantitative evidence from
analytical ultracentrifugation for 62% monomer and 38% dimer
in solution (Tochowicz et al., 2011). A crystal structure suggests
a tilted dimer with a symmetric interface about blades II and III.
Mutations at this interface indicate its relevance to collagen
degradation, migration, and proposed ‘‘biological dimerization’’
(Tochowicz et al., 2011). The isolated HPX domain was found
to be monomeric in solution (Basu et al., 2012; Overall et al.,
2000).
In collagenolysis by MMPs, the HPX and catalytic domains
working in tandem have been expected to loosen the collagen
triple helix to expose a single strand for digestion (Bode et al.,
1994). Due to the size and insolubility of intact collagen, investi-258 Structure 23, 257–269, February 3, 2015 ª2015 Elsevier Ltd All rgations of this question and its details have relied heavily on self-
assembling triple-helical peptides (THPs) as collagen mimetics
(Fields, 2010). THPs have long served as excellent substrates
to study the triple-helical peptidase activity and specificity of
MMPs (Lauer-Fields et al., 2009; Minond et al., 2007; Robichaud
et al., 2011). Most exosites of THP binding to the HPX domain of
MMP-1weremapped to blade I (Arnold et al., 2011; Lauer-Fields
et al., 2009). Recent structural models of complexes of MMP-1
with THPs have been interpreted to suggest significant destabi-
lization of the triple helix (Bertini et al., 2012) or a small degree of
bending and shift of the triple helix (Manka et al., 2012).
Despite the similarity of 3/4 and 1/4 fragments generated, col-
lagenolytic MMPs may differ partly in collagen sequence recog-
nized and in mode of engagement of the triple helix. MT1-MMP
joinsMT2-MMP, MMP-8, andMMP-13 in hydrolyzing more ther-
mally stable triple helices and in preferring an aromatic side chain
at P1
0 (Minond et al., 2007). AlthoughMMP-1 prefers extension of
native collagen sequence C-terminal to the scissile bond, MMP-
8, MMP-13, andMT1-MMP prefer N-terminal extension of native
collagen sequence (Robichaud et al., 2011). MT1-MMP appears
to bind collagen at a site different from that of MMP-1 and -8
(Tam et al., 2004). The promise and need for selective inhibitorsights reserved
Table 1. Steady-State Kinetic Parameters for Hydrolysis of fTHP-15 and FS-6 by MT1-MMP Variants at 27C, pH 7.5
Enzyme variant
fTHP-15 FS-6
kcat/Km, M
1 s1 kcat, s
1 Km, nM kcat/Km, M
1s1 kcat, s
1 Km, nM
Wild-type CATa 7,660 ± 30 0.068 8,900 ± 200 1,180,000 ± 80,000 1.90 1600 ± 200
Wild-type ECDb 26,700 ± 100 0.022 820 ± 10 589,000 ± 10,000 0.62 1100 ± 30
ECD R330A 18,500 ± 100 (70%) 0.018 980 ± 10 597,000 ± 5,000 0.80 1300 ± 20
ECD R343A 14,900 ± 100 (56%) 0.064 4,300 ± 100 575,000 ± 17,000 0.59 1000 ± 50
ECD R345A 17,900 ± 100 (67%) 0.030 1,700 ± 20 819,000 ±18,000 0.69 850 ± 30
ECD N347A 28,400 ± 100 (106%) 0.022 790 ± 1 0 564,000 ± 10,000 0.58 1000 ± 30
ECD F360G 16,100 ± 100 (60%) 0.027 1,700 ± 20 535,000 ± 5,000 0.74 1400 ± 20
ECD E392A 15,500 ± 100 (58%) 0.024 1,600 ± 20 514,000 ± 9,000 0.53 1000 ± 30
aCAT, catalytic domain.
bECD, ectodomain.(Basu et al., 2012; Remacle et al., 2012) and insight into mecha-
nistic differences among collagenolytic MMPs demands struc-
tural study of collagen triple helix interactions with MT1-MMP.
This work investigates the mode of collagen I-based THP
binding to the HPX domain of MT1-MMP. Solution nuclear mag-
netic resonance (NMR) and enzymatic assay of mutations map-
ped the interface between the HPX domain and THP. Distances
were measured between spin-labeled THP samples and the
HPX domain of MT1-MMP by NMR detection of paramagnetic
relaxation enhancements (PREs). The PREs have been used in
calculating the solution structural model of the predominant
orientation of this transient complex of modest affinity. The inter-
facial contacts, distinctive translational position, a potential site
for selective inhibition, interdomain flexibility, and implications
for engagement of the collagen triple helix by the ectodomain
of MT1-MMP are discussed.
RESULTS AND DISCUSSION
NMRMapping of the THPBinding Site in theHPXDomain
For investigating the site of collagen triple helix binding in the
HPX domain, we assigned 95% of its backbone amide reso-
nances at pH 5 by triple resonance NMR. The methyl and carbon
resonances of the Leu/Val/Ile side chains of the HPX domain
were assigned by interpreting HMCBCA spectra together
with heteronuclear multiple quantum coherence (HMQC), triple
resonance, and 13C- and 15N-edited NOESY (nuclear Over-
hauser effect spectroscopy) spectra (Figures S1A and S1B avail-
able online). To assign peaks of arginine side chains in the inter-
face, each candidate was replaced by an alanine (Figure S1C).
Changes introduced to 15N TROSY NMR spectra of the HPX
domain by several additions of a1(I)772–786 THP include both
shifts and broadening. The association fails to saturate with
additions up to 4-fold molar excess. The chemical shift perturba-
tions are generally small, but larger where the peaks also
undergo severe line broadening. The side chain Nε-Hε peaks
of Arg330, Arg343, and Arg345 are considerably broadened
and shifted by the THP (Figure 1B). The backbone peaks most
shifted by the THP center on blade I but span from blade II to
blade IV, namely Gly331, Asn347-Met350, Glu392, and Asp504
(red or purple in Figures 1A and 1C). The THP induces locally
extreme line broadening in blade I at Arg330-Met333, Val344,
Arg345, Asn347, and Met350, which are located in the loopsStructure 23, 25connecting b-strand 1 with 2, b-strand 3 with 4a, and the bulge
in the outermost strand (Figures 1A and 1C). The broadening is
also evident at Phe360 of the helix connecting blades I and II
and Gly507 at the C terminus of blade IV (Figure 1C). The pro-
gressive THP-induced shifts and broadenings of the NMR peaks
indicate the titrations to be intermediate on the time scale of
NMR chemical shift differences between free and bound states.
This suggests that the association with the THP is a dynamic
equilibrium, in which the interfacial residues (Figure 1A) experi-
ence fluctuation between the free and THP-bound states.
Impact of THP-Binding Patch on Triple-Helical
Peptidase Activity
We evaluated the contribution of this THP-binding patch to pro-
cessing of a collagen triple helix by the ectodomain. Steady-
state kinetic parameters of triple-helical peptidase activity were
fitted to progress curves of fluorescence increase with hydroly-
sis (Palmier and Van Doren, 2007). The HPX domain in the ecto-
domain enhances the catalytic efficiency kcat/Km toward the
fTHP-15 substrate over that of the catalytic domain alone,
through a clearly more favorable Km (Table 1). In proteolysis of
the linear peptide substrate FS-6, however, the ectodomain ex-
periences decreases relative to the catalytic domain of 2-fold in
kcat/Km, 3-fold in kcat, and 1.5-fold in Km (Table 1). The catalytic
turnover rate constant kcat for THP substrates is also 3-fold
higher by the catalytic domain than the ectodomain. These ob-
servations suggest that the HPX domain may modestly hinder
substrates from entering or cleaved products from leaving the
catalytic cleft.
Since THP perturbations of amide NMR peaks of the HPX
domain might occur not only at the interface but potentially else-
where through indirect effects, site-directed mutagenesis was
used to examine residues of the HPX domain suggested by
NMR to interact with THPs. Surface residues Arg330, Arg343,
Arg345, Asn347, and Glu392 (Figure 2A) were selected for
alanine substitution from among the residues with NMR peaks
most affected by the a1(I)772–786 THP. Arg330 and Glu392
form a salt bridge across the interface between blades I and II
(Figures 1A, 2A, and 5B). Phe360 with its side chain exposed
was mutated to glycine for full removal of a hydrophobic side
chain, but it may also enhance backbone flexibility. The variants
exhibit similar catalytic efficiency upon the linear peptide sub-
strate FS-6, suggesting that the mutations in the HPX domain7–269, February 3, 2015 ª2015 Elsevier Ltd All rights reserved 259
Figure 2. Triple-Helical Peptidase Activity of the Ectodomain of MT1-MMP Impaired by Alanine Substitutions at the THP Binding Site of its
HPX Domain
(A) Residues that impair triple-helical peptidase activity when mutated are shown with sticks and labels.
(B) The catalytic efficiency kcat/Km and Michaelis constant Km of the triple-helical peptidase activity towards fTHP-15 by the variants of the ectodomain (catalytic
through HPX domains) of MT1-MMP at 27C (pH 7.5) are from fits of two progress curves (Palmier and Van Doren, 2007). The uncertainties plotted are 3-fold the
fitting errors.
(C) Catalytic turnover kcat is plotted versus Km for THP hydrolysis. Variants falling to the right of the trend line through theWT point are decreased in kcat/Km of the
triple-helical peptidase activity.do not affect the catalytic domain, but that the R345A mutation
appears to enhance Km slightly for the linear peptide (Table 1).
Assays of the catalytic domain only suggest the maximal ef-
fects of removal of the HPX domain on triple-helical peptidase
activity are the 3.5-fold decrease of kcat/Km and 10.8-fold in-
crease of Km (Table 1; Figure 2B). The R343A mutation realizes
half this much impairment of Km, i.e. by 5.2-fold, and 44% loss
of catalytic efficiency. The R345A, F360G, E392A lesions in-
crease Km by2-fold and decrease catalytic efficiency by about
33%, 40%, and 42%, respectively (Figure 2B). Consequently,
these four residues may contribute to productive binding and
processing of the THP substrate. The 30% loss of kcat/Km and
increase of Km of the R330A mutation are more subtle. The
lack of effect of the N347A mutation suggests this position plays
no direct role. The muted mutational effects on catalytic effi-
ciency appear to be related to the trend of kcat increasing with
Km (Figure 2C), similar to the positive correlation of kcat with Km
as the length of the triple-helical substrate was varied (Robi-
chaud et al., 2011). Less affinity for a substrate may correlate
with faster off-rate of the cleaved product to hasten kcat and
account for partial correlation of kcat with Km (Figure 2C).
Side Chains of the THP that Contact the HPX Domain
Saturation transfer difference (STD) NMR identified groups in
a1(I)772–786 THP that contact the HPX domain. Saturation of
an upfield methyl peak unique to the spectrum of the HPX
domain spread across the domain and across its interface to
several aliphatic groups of the THP in contact (Figure 3B). The
side chains of the THP in STD contact and sufficiently resolved
in 1H NMR spectra with the HPX domain include the Pro g and
d at the P3 position in the substrate sequence, as well as Ile g
at P1
0, Ala b at P20, Gln g at P40, and Val g at either of the spectrally
overlapped P7
0/P80 positions (Figures 3B and 3E). The peaks
from all three chains of the THP at the P3 Pro d and P2
0 Ala b po-
sitions received saturation from the HPX domain (Figures 3B–
3D). This indicates that the THP binds as an average of rotational260 Structure 23, 257–269, February 3, 2015 ª2015 Elsevier Ltd All rorientations. The rotational averaging, fast-intermediate ex-
change regime, and the limited effects of the mutations suggest
modest affinity and dynamic averaging in this complex.
Monomer in Solution
The quaternary structure of the HPX domain is relevant to its
recognition of collagen-mimicking THPs. The HPX domain was
characterized by hydrodynamic methods, with an interest in
any self-association or dependence on [CaCl2], which is present
in the extracellular matrix at 2 to 3 mM and in several crystal
structures of HPX domains, beginning with MMP-2 (Libson
et al., 1995). However, a sodium ion appears at the correspond-
ing site where the four blades meet in the crystal structure of the
HPX domain of MT1-MMP (Tochowicz et al., 2011). Migration of
the HPX domain (folded with EDTA present) on an analytical gel
filtration column is consistent with a theoretical monomeric MW
of 23 kDa and is unchanged from 50 to 200 mM, suggesting lack
of self-association (Figure S2A). After addition of 5 mM CaCl2 or
5 mM EDTA, the rate of migration is retained within the uncer-
tainties (Figure S2A). This suggests the monomeric behavior to
be unaffected by calcium ions. Dynamic light scattering (DLS) in-
dicates the HPX domain to be monodisperse and suggests
Ca2+-free samples to have a hydrodynamic radius of 2.3 nm,
with apparent MW of 22 kDa (Figure S2B). DLS of the fraction
eluting from the gel permeation column in 5 mM CaCl2 suggests
an apparent hydrodynamic radius of 2.05 nm and apparent MW
of 17 kDa (Figure S2C). Addition of 5 mM CaCl2 fails to perturb
the 15N TROSY NMR spectrum (Figure S2D), further suggesting
a lack of interaction of calcium ions with the HPX domain of
MT1-MMP. 15N NMR cross-correlated relaxation (Figure S2E)
was used to compare rotational correlation times, tc, at 37
C
for samples free of Ca2+ (pH 5), in 5 mM Ca2+ (pH 7), and in
5 mM EDTA with 2.5 mM Ca2+ (pH 7) and suggested them to
be 10.8 ± 0.2 ns, 11.75 ± 0.5 ns, and 12.2 ± 1.2, respectively
(Table S1). These conditions without andwith Ca2+ ions available
are all much closer to the theoretically predicted tc values of aights reserved
Figure 3. Side Chains of the THP in
Contact with the HPX Domain of MT1-
MMP Revealed by Saturation Transfer Dif-
ference NMR
(A) STD spectrum of 400 mM a1(I)772–786 THP
(pH 5, 25C) without addition of HPX domain.
(B) STD spectrum of the THP after addition of
10 mM HPX domain. Side chains of the THP
receiving saturation from the HPX domain and
assigned without ambiguity are labeled.
(C) 1D projection of and (D) 2D 13C HSQC of the
same THP are aligned for comparison.
(E) THP side chains in contact with the HPX
domain are labeled on the homology model using
the nomenclature of protease substrates relative
to the scissile bond at P1-P1
0. Leading, middle, and
trailing chains are colored dark red, green, and
blue, respectively.monomer of 9.1 ± 0.6 ns than to the symmetric dimer described
(Tochowicz et al., 2011), which has a theoretically predicted tc of
almost 24 ns (Table S1). Thus, the samples of HPX domain of
MT1-MMP studied are predominantly monomeric, consistently
across a range of relevant conditions.
Close Approaches of Spin-Labeled THPs with the HPX
Domain
We sought to dock a1(I)772–786 THPwith themonomer from the
crystal structure of the HPX domain of MT1-MMP (Tochowicz
et al., 2011). We prepared a homology model of this THP (Fig-
ure 3E) from the crystal structure of a homologous THP (Manka
et al., 2012) as template. We measured intermolecular distances
using a method effective for complexes of modest affinity in
dynamic equilibrium. The approach places spin labels in one
partner in order to introduce distance-dependent NMR line
broadenings known as PREs (Clore and Iwahara, 2009). We
introduced a nitroxide spin label at the d position of the six-
membered side chain ring of the artificial amino acid 2,2,6,6-tet-
ramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid (TOAC),
incorporated into the proline-poor region of a1(I)772–786 THP.
The THP samples with TOAC incorporated at either P4
0 or P70
formed a triple helix, as evident from the positive feature at l =
225 nm in the CD spectra at 22C (Figure S3).
We monitored the effects of TOAC substitution upon folding
stability of the THP and the binding interface of the HPX domain.Structure 23, 257–269, February 3, 2015TOAC substitution at P4
0 decreased Tm to
23C and at P70 to 27.5C (Figure S3),
each below the Tm of 41
C of the native
sequence. To stay well below the melting
transitions, NMR experiments were
performed at 12.5C using TOAC substi-
tution at P4
0 or at 17C using TOAC
substitution at P7
0. When added to
the HPX domain, the TOAC-substituted
THPs (reduced with ascorbate to avoid
paramagnetic broadening) induced
similar patterns of line broadening to the
unmodified a1(I)772–786 THP (Figure S4).
a1(I)772–786 THP broadened the peaksof Phe360 and Ser470 more than the TOAC-containing variants.
The TOAC substitution at P7
0 heightened line broadenings for
residues of blades II to IV in and near the interface identified us-
ing unmodified a1(I)772–786 THP (Figures 1C and S4), as well as
at five more distant residues of blade III, suggesting a subtle
perturbation of part of blade III (Figure S4). Nonetheless, the
shared locations of line broadening introduced by all THPs indi-
cate the same binding region on the HPX domain.
PREsweremeasured asG2 differences between the relaxation
rate constants in the paramagnetic and diamagnetic states (the
latter via ascorbate reduction of the nitroxide) (Figure S5). The
highly distance-dependent PREs emanating from the TOAC
placed in the P4
0 or P70 position of the THP sequence are plotted
in Figure 4. The spin labeling of the P4
0 position of the THP intro-
duced many strong PREs to blades I and II (Figures 4A and 4C),
resembling the spatial pattern of peak perturbations by the un-
modified THP (Figure 1). The largest of these PREs, i.e., 56 s1
to Gly331 (Figure 4A), suggests this to be the closest approach
of the HPX domain to the P4
0 position in the THP. This point in
blade I lies in the b-hairpin loop nearest the central axis of
pseudo four-fold symmetry and is represented by the purple
sphere nearest a gray sphere in Figure 4C. The next largest
PREs (Figure 4A) and next closest approaches radiate outward
from Gly331 to Asp351 and Met350 of the neighboring loop in
blade I to a Val473 methyl group in the innermost b-hairpin
loop of blade IV, and to Gly377 of the innermost b-hairpin loopª2015 Elsevier Ltd All rights reserved 261
(legend on next page)
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of blade II (purple in Figure 4C). The PREs together suggest that
the P4
0 region of the THP passes near blades I and II and the
central loop of blade IV of the HPX domain.
PREs from the TOAC at the P7
0 position appear in all four
blades of the HPX domain at almost periodically repeating inter-
vals (Figure 4B, left panel), suggestive of similar distances of
TOAC at P7
0 to all four blades. Extreme broadening of amide
peaks of Gly377, Gly425, and Asp471 (Figure 4B) suggests
them to make the closest approaches to the TOAC at P7
0 of
the THP, likely within 13 A˚. These three residues are located
in the first and innermost b-hairpin loops of blades II, III, and IV
(three red spheres nearest a nitroxide in Figure 4D). The large
PRE from the P7
0 TOAC to Leu329 indicates the first b-hairpin
loop of blade I to be nearby as well. These PREs suggest
positioning of the P7
0 TOAC adjacent to these four inner loops
of the HPX domain, with smaller PREs radiating outward
(Figure 4D).
Structure Reveals Mode of THP Binding and Contacts
with Blades I and II
Significant PREswithG2 values above 10 s
1 for amide groups or
above 5 s1 for methyl groups were converted using Equation 1
into distance restraints for docking the crystal structure of the
HPX domain of MT1-MMP with the homology model of a1(I)
772–786 THP. 108 distance restraints from the HPX domain to
the spin label at P4
0 and 111 to the spin label at P70 were obtained
(Table 2). Ambiguous distance restraints at the interface supple-
mented the docking calculations, i.e. five residues highlighted
in Figure 1A and 12 THP residues highlighted in Figure 3E. The
ensemble of 15 lowest energy structures converged with a
backbone root-mean-square deviation of 0.31 A˚ to the mean
(Figure 5A; Table 2). Comparison of PRE-estimated distances
with the distances in the best-scoring structure and a Q-factor
of 0.13 indicate good agreement (Figure S6; Table 2).
The N-terminal half of the a1(I)772–786 THP traverses the
interface between blades I and II (Figures 5A and 5C), covering
the pit in this interface, which was designated the S10
0 subsite
in MMP-1 (Manka et al., 2012). The THP passes across the
pseudo four-fold axis of symmetry among the blades andmakes
a 45 angle with this axis (Figure 4C). The structures of the
ensemble bury an average of 1100 A˚2 of surface area in the inter-
face between the THP and blades I and II of the HPX domain.
While the ensemble represents the most probable structure in
solution in a single rotational orientation (Figure 5A), the contacts
with all three chains at the P3 and P2
0 positions (Figure 3) imply an
average of rotational orientations actually present in solution. In
the most probable orientation represented by the NMR-eluci-
dated complex, the trailing (T) chain of a1(I)772–786 THP con-Figure 4. Proximity of the THP to the HPX Domain Revealed by PREs f
(A) PREs from TOAC at the P4
0 position of the THP (see inset) were detected on a
methyl groups are organized by residue type. PREs are quantified as G2 = R2,para
and R2,dia. Each asterisk (*) of the x axis refers to the proS methyl group; the oth
(B) PREs from TOAC at the P7
0 position (see inset) to the amide and methyl grou
(C) Significant PREs from TOAC at P4
0 to amide or methyl groups are marked on th
designates PREs > 25 s1, while dark blue designates smaller PREs > 10 s1 to am
Ca traces (red, green, and blue).
(D) PREs from TOAC at P7
0 are plotted likewise but with PREs > 25 s1 colored b
spheres mark the approximate positions of the nitroxide group at P40 (C) or at P7
Structure 23, 25tributes the majority of the contacts with the HPX domain: Hyp
at P5, Pro at P3, Gln at P2, Ile at P1
0, Ala at P20, Gln at P40, and
Arg at P5
0 (Figure 5). The leading (L) chain places the Ile at P10,
Gln at P4
0, and Val at P70 in contact with blade I (Figure 5A).
Both Hyp at P5 and Gln at P2 from the middle (M) chain make
contact with blade II. The side chain of Gln at P4
0 in the L chain
donates hydrogen bonds to Glu332 in blade I (Figure 5B). In
the T chain, Gly at P3
0 and the side chain of Gln at P40 accept
hydrogen bonds donated by Arg330 from blade I, while Ala at
P2
0 donates a hydrogen bond to Glu392 (Figure 5B). Alanine sub-
stitutions of Arg330 or Glu392, engaged in a salt bridge, impaired
triple-helical peptidase activity (Figure 2A; Table 1). The R343A
and R345A mutations may have impaired activity indirectly by
disrupting the hydrogen bonding of Glu332, which forms salt
bridges with both arginine residues (Figure 5B). Gln359 ap-
proaches the Hyp at P5 in the M chain (Figure 5C). The rim of
the pocket between blades I and II makes hydrophobic contacts
with the T chain (Figure 5C): A methylene group of Arg330 ap-
pears to touch Ala at P2
0. Gly352 contacts Hyp at P5. Phe360
meets the methylene groups of Pro at P3 and Gln at P2. Ala393
and the methylene groups of Glu392 contact Ile at P1
0.
Conserved versus Protease-Specific Interfacial
Contacts
Arg330 andGlu332 ofMT1-MMP, which hydrogen bond the THP
in the coordinates, are conserved among most human MMPs
(Figures 5B and 5D). Phe360 that presents a hydrophobic sur-
face to the THP is conserved among the membrane-type and
collagenolytic MMPs (Figures 5C and 5D). In contrast, THP-bind-
ing residues Glu392 and Ala393 are shared only between MT1-
MMP and MT2-MMP (Figures 5B–5D), while Gln359 is shared
only withMT5-MMP (Figures 5C and 5D). These latter three inter-
facial residues could potentially be targeted in development of
therapeutic or diagnostic agents with selectivity for membrane-
type MMPs such as MT1-MMP.
A tumor-suppressing inhibitor of MT1-MMP was proposed to
bind in the central pocket between Arg330, Met422, and Ser470
where the four blades meet (Remacle et al., 2012). This binding
site partially overlaps the THP-binding interface in Figures 5A
and 5C, raising the question of the inhibitor competing with
binding of collagen.
Positioning of THP with Respect to Digestion
The NMR-based structural model (Figure 5) could represent a
partial or initial association of MT1-MMP with the collagen triple
helix, in which the HPX domain enhances the affinity (Figure 2;
Table 1). Structural superposition of the a1(I)772–786 THP com-
plexes with MT1-MMP and full-length MMP-1 highlights therom Nitroxide Spin Labels
mide groups (left, blue) and methyl groups (right, blue) of the HPX domain. The
 R2,dia. The errors of G2 are propagated from the fitting uncertainties of R2,para
er methyl group is proR.
ps are plotted with dull red.
e crystal structure of the HPX domain as spheres or sticks, respectively. Purple
ide groups and > 5 s1 tomethyl groups. The chains of the THP are plottedwith
right red and the smaller PREs colored dull red. In (C) and (D), the gray dotted
0 (D) of the THP. See also Figure S5.
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Table 2. Structural Statistics of PRE-based Structural
Ensembles
PDB ID 2MQS
BMRB code 25048
Restraints to TOAC at P40 of THP HN 25 aa
a *3 TOAC = 75
HCH3 11aa
b *3 TOAC = 33
Restraints to TOAC at P70 of THP HN 23 aa
c *3 TOAC = 69
HCH3 14 aa
d *3 TOAC = 42
Total PRE-based distance
restraints = 219
Ambiguous Restraints 5 aae of HPX domain and
12 aaf of THP
RMS Deviations
All backbone atoms (A˚)g 0.31
All heavy atoms (A˚)g 0.36
Backbone to crystal
structure of HPX
domain (3C7X A˚)h
0.62
Q-factor for PRE-based
distance restraintsh
0.13
Number of violations larger than
2 or 1 A˚
1i, 3j
Statistics of Overall Structural Quality Mean Score
Procheck G-factor (all dihedrals) 0.01
Molprobityk 1.44
Residues in most favored regions
of Ramachandran plotl
84.5%
Residues in additional allowed
regions
14.5%
aA327, L329, G331, F341, M350, D351, R362, I368, E373, K375, D376,
G377, F379, A393–E396, G425, Y428, N439, S466, G469, Y476, F477,
K482.
bL329(d2), L364(d2), L419(d1), L442 (d1, d2), V344(g1, g2), V349(g1),
V380(g2), V473(g1, g2).
cL329, F341, R345, N346, G352, E373, G377, D391, A393 - L395, F420,
W421, G425–Y428, E441, F467– G469, D471, Y476.
dL329(d2), L419(d1), L442 (d2), L491(d1), V335(g2), V344(g1, g2), V349(g1),
V380(g1, g2), V389( g1, g2), V473(g1, g2).
eR330, R343, R345, F360, E392.
fP(P3), I(P10), A(P20), Q(P40) 3 three chains of homotrimer.
gCalculated based on the 15 lowest energy structures.
hCalculated based on the best structure ranked by HADDOCK score.
iL442(d2).
jL395(HN), Y428(HN), G352(HN).
kMolprobity score combines the clash score, rotamers, and Ramachan-
dran evaluation into a single score.
lRamachandran plot analysis (%) from Procheck-NMR.similarity in the angle and surface at which the THP crosses the
two different HPX domains (Figure 6A). However, in the MT1-
MMP complex, the THP is translated by nine residues from its
position in the MMP-1 complex. That is, Ile at P1
0 at the scissile
bond lies over the pocket of MT1-MMP corresponding to the
S10
0 subsite of MMP-1 (Figure 6A). In the MMP-1 complex, Leu
at P10
0 of the same THP instead lies over S100. Independent
NMR analysis of interactions between a1(I)772–786 THP and
the MT1-MMP HPX domain also shows shifted binding of the
THP (C. Luchinat, M. Fragai, L. Cerofolini, S. Amar, S. Pahwa,264 Structure 23, 257–269, February 3, 2015 ª2015 Elsevier Ltd All rand G.B.F., unpublished data), using the same approach that
did not show shifted binding of the THP to MMP-1 (Bertini
et al., 2012). The translational shift seems consistent with the re-
ports of differences in collagen binding by MMP-1 and MT1-
MMP and their HPX domains (Minond et al., 2007; Robichaud
et al., 2011; Tam et al., 2004). However, the NMR structure (Fig-
ure 5A) suggests that if the catalytic domain is positioned like in
MMP-1, it would be too far to reach the scissile bond (Figure 6A).
A change in arrangement seems necessary for the collagen triple
helix to interact with both soluble domains of MT1-MMP during
collagenolysis. The large shift and transient nature of the MT1-
MMP complex suggests that more than one rearrangement
could be possible.
Two potential modes of binding of the triple helix for produc-
tive hydrolysis by MT1-MMP are considered: a sliding model
or a claspingmodel. If the side-by-side positioning ofMMP-1 do-
mains in THP complexes (Bertini et al., 2012; Manka et al., 2012)
(gray in Figure 6A) could represent MT1-MMP complexes, that
would suggest shifting of the triple helix by nine residues and
around 24 to 28 A˚ in order to place the scissile GlyIle/Leu
peptide bond at the active site. Greater affinity of the catalytic
domain for the proline-poor region of the triple helix might facil-
itate the hypothetical shift. The modest affinity and transient
binding of the THP to the HPX domain might permit the THP to
move across MT1-MMP to place the scissile bond in the active
site and shift Leu at P10
0 into the S100 subsite like in MMP-1.
Consider if, however, the THP bound to the HPX domain of
MT1-MMP (Figure 5) does represent the final translational posi-
tioning of collagen triple helix bound to full-length MT1-MMP.
The hypothesis that the HPX domain folds back upon the
collagen triple helix at the active site (Bode, 1995) would then
offer the needed proximity of both domains to the scissile
bond region (Figure 6B). The ease of rotating the orientations
between the catalytic and HPX domains is suggested by the
tremendous range of fluctuating orientations between the corre-
sponding domains of MMP-1 (Cerofolini et al., 2013), which was
proposed to generalize to all MMPs due to the greater length of
their flexible linkers (Bertini et al., 2008). We used atomic force
microscopy (AFM) of the ectodomain to investigate this hypoth-
esis of loose tethering of the catalytic to HPX domain of MT1-
MMP, as well as the range of their relative positions. The features
in AFM images aremonodisperse. In some features, the domains
appear to be stacked vertically above the mica surface. In many
other features, the catalytic and HPX domains appear to be later-
ally adjacent and distinct (Figures 7A–7C). The distances be-
tween the highest points of the two domains mostly range from
4 to 7 nm, with greater extensions to more than 10 nm also
observed (Figure 7). The variable distance between the domains
suggests the extensibility and flexibility of the 35-residue linker
between the domains. This provides freedom of diffusional posi-
tioning of the domains. Such repositioning might aid the diffusive
movement of MT1-MMP ectodomain on collagen (Collier et al.,
2011; Overall and Butler, 2007). The long, flexible linker and var-
iable separation between the domains suggests that they are
potentially free enough to reorient between the side-by-side ori-
entations observed for MMP-1 and an arrangement to sandwich
the collagen triple helix between the two domains. Simulation of
a hypothetical progression of domain orientations suggests that
the linker between the domains is long enough for a claspingights reserved
Figure 5. Structural Ensemble of the Complex of THP with HPX Domain of MT1-MMP and Interface between Scissile Bond Region and
Blades I and II
(A) The ensemble of 15 best low-energy structures are plotted with the L, middle, and T chains of the THP colored red, green, and blue, respectively, and blades I
to IV colored according to Figure 1A. THP residues in contact with the HPX domain are plotted with sticks. See also Figure S6.
(B) Hydrogen bonds are shown as dashed lines across the interface and to their neighbors, in the structure with best HADDOCK score.
(C) Hydrophobic interactions in the interface are shown. Carbon atoms with distances <4 A˚ across the interface are shown with dots and small spheres.
(D) Sites of THP contact are marked on the alignment of human MMP sequences. Bright blue indicates the most conserved positions in sequence and bright red
the least conserved. Darker shades denote intermediate levels of conservation. Sequence omissions of 10 and 30 residues are indicated by two dashes.arrangement (Movie S1), as hypothesized for binding a collagen
monomer (Bode, 1995).
Conclusions
The structure of the complex of the HPX domain of MT1-MMP
with a collagen I-derived THP has been captured by NMR
detection of intermolecular PREs to spin labels, despite the
modest affinity and transiency of the complex. Part of the inter-
face is conserved and part is unique to membrane-type MMPs
and could be exploited for selective inhibition to increase ther-
apeutic potential of inhibiting tumor cell invasion and preserving
the left ventricle after heart attack. There is enough freedom
between the catalytic and HPX domains not only to bind adja-Structure 23, 25cent sites on the collagen triple helix but also to reorient
for movement on collagen and possibly to embrace a collagen
monomer between the domains, a potentially distinctive mode
of action.
EXPERIMENTAL PROCEDURES
Folding of Domains
Domains of MT1-MMP were expressed in Escherichia coli, labeled with iso-
topes for NMR, folded from inclusion bodies, and purified in denaturant as
described in Supplemental Experimental Procedures. The HPX domain was
folded at pH 5 in the absence of Ca2+, or using 10 mM CaCl2 at pH 7 for com-
parison. Folding of the catalytic domain and ectodomain (C127S-substituted)
and its variants used 10 mM CaCl2 at pH 7–7.5.7–269, February 3, 2015 ª2015 Elsevier Ltd All rights reserved 265
Figure 6. Collagen Triple Helix Positioning Across MT1-MMP HPX
Domain and Full-Length MMP-1
(A) The complex of THP with HPX domain of MT1-MMP (colored as in Figure 5)
is superimposed via the HPX domain with the NMRmodel of the THP complex
with full-length MMP-1 (Bertini et al., 2012) colored gray. The scissile Gly-Ile
peptide bond in the MMP-1 complex is shown with sticks within the gray oval.
The horizontal line marks potential distances of translation between the scis-
sile bond positions in the MT1-MMP complex and the MMP-1 complex.
(B) Illustration of the hypothesis that the catalytic domain (cyan) of MT1-MMP
folds over the collagen triple helix to form a sandwich with the HPX domain.
The scissile bond is highlighted by an arrow and a cyan oval at the active site.
Calcium and zinc ions are indicated by gold and gray spheres, respectively.
Hypothetical paths of the interdomain linker are colored gray. SeeMovie S1 for
a simulated, speculative trajectory of reorientation between the hypothetical
modes of binding of panels A and B.
Figure 7. AFM Images Reveal Variable Distances between the Cata-
lytic and HPX Domains of MT1-MMP, Suggesting Flexible Tethering
and Diffusion of the Domains
(A–C) Features with distances between high points of the domains of 4.2 nm
(A), 6.1 nm (B), and 8 nm (C). The vertical scale rises to 4 nm and the lateral
scale bar represents 5 nm.
(D) The histogram shows the distribution of peak-to-peak distances (N = 134
features) between high points of adjoining domains in 150 mM NaCl, 10 mM
CaCl2, at pH 7.5. The bin size is 0.45 nm.a1(I)772–786 THP
The peptide ((Gly-Pro-Hyp)4-Gly-Pro-Gln-Gly-Ile-Ala-Gly-Gln-Arg-Gly-Val-
Val-Gly-Leu-Hyp-(Gly-Pro-Hyp)4-Gly-Tyr-NH2)3 was synthesized and charac-
terized as described (Lauer-Fields et al., 2009). Underlining marks residues
772–786 of the type I collagen a1 chain. The NMR peak assignments of this
THP are available (Bertini et al., 2012).
NMR Spectroscopy and Titrations to Map THP Binding Site on HPX
Domain
NMR spectra of 15N/2H- or 15N/13C/2H-labeled HPX domain at 0.3–0.4 mM (pH
5 or 7) were acquired on a Bruker Avance III 800 MHz spectrometer with TCI
cryoprobe. NMR peak assignments are described in Supplemental Experi-
mental Procedures. Methyl peak assignments are depicted in Figure S1.
Stock solutions of a1(I) 772–786 THP were prepared at 8 to 9 mM in folded
trimer in 10 mM sodium acetate (pH 5), 0.02% NaN3, and 7% D2O, as deter-
mined by A280 and extinction coefficient of 3591 M
1 cm1. 15N BEST-TROSY266 Structure 23, 257–269, February 3, 2015 ª2015 Elsevier Ltd All r(Lescop et al., 2010) spectra of 15N-labeled HPX domain were collected at
25C with progressive additions of small volume aliquots of the a1(I) 772–
786 THP.
Site-Directed Mutagenesis of Prospective THP Binding Site
Mutations in the HPX domain were generated in the ectodomain construct
(which also contains the catalytic domain and intervening linker) using Quik-
Change mutagenesis (Stratagene), and confirmed by DNA sequencing.
Enzyme Kinetic Assays
The triple-helical peptidase activity of wild-type and mutant ectodomains of
MT1-MMP was detected as the increased fluorescence of fTHP-15 with
sequence of ((Gly-Pro-Hyp)5-Gly-Pro-Lys(Mca)-Gly-Pro-Gln-GlyLeu-Arg-
Gly-Gln-Lys(Dnp)-Gly-Val-Arg-(Gly-Pro-Hyp)5-NH2)3 with Mca as fluorophore
and Dnp as quencher (Robichaud et al., 2011). The linear peptide substrate
FS-6 (Mca-Lys-Pro-Leu-GlyLeu-Dpa-Ala-Arg-NH2) (Neumann et al., 2004)
served as a control. Hydrolysis of these substrates at 27C in 20 mM Tris-
HCl (pH 7.5), 10mMCaCl2, 10 mMZnCl2 wasmonitored with a BioTek Synergy
MX plate reader as fluorescence emission at l = 393 nm using excitation of
fTHP-15 at l = 324 nm and FS-6 at 328 nm. Km and kcat were estimated by
fitting progress curves at two substrate concentrations (Palmier and Van Do-
ren, 2007). The concentration of intact enzyme active sites was quantified by
titration with the inhibitor galardin (GM6001, EMD).
Homology Model of the THP
The crystal structure of a1(II) THP (Manka et al., 2012) (Protein Data Bank
[PDB] ID 4auo) provided the template for creating the homology model
of a1(I) 772–786 THP, with modifications to sequence made in PyMol.
The homology model was refined by energy minimization followed by molec-
ular dynamics to equilibrate it in water solvent using GROMACS (Pronk et al.,
2013).ights reserved
STD NMR to Map Binding Sites on THP
STD relied on transfer of selective saturation from a dilute protein (0, 3, 10,
or 30 mM HPX domain herein) to the ligand, which was 0.4 mM a1(I)772–786
THP at 25C. The HPX domain was selectively saturated in its methyl region
at 0.5 ppm. The reference spectra utilized dummy saturation off-resonance
at 20.7 ppm.
Measurement of PREs
To measure distances between a1(I)772–786 THP and the HPX domain, PREs
were introduced to the complex by the nitroxide spin label of the TOAC substi-
tution for either Gln at P4
0 or Val at P70 (Figures 4A and 4B). Each TOAC-labeled
THP was present at 2-fold molar excess over the 2H/15N/13C-1H3-labeled HPX
domain. The diamagnetic reference state of each complex was prepared by
reducing the nitroxide with 20 mM sodium ascorbate for at least 2 hr. Amide
andmethyl proton relaxation wasmeasured before and after ascorbate reduc-
tion using a Carr-Purcell-Meiboom-Gill (CPMG) sequence that suppresses
1H-1H J-couplings (Aguilar et al., 2012). Detection of amide groups used
CPMG relaxation periods of 0, 4, 8, 12, 16, and 20 ms added to the 15N
HSQC. Methyl groups were detected by HMQC joined with CPMG relaxation
periods of 0, 4, 8, 12, 16, 24, and 32ms.R2,para andR2,dia refer to the respective
paramagnetic and diamagnetic states. Each PRE is the difference: G2 = R2,para
 R2,dia.
Distance Restraints from PREs
PRE-based distances r from the nitroxide of the TOAC to each amide or
methyl group of the HPX domain were calibrated using Equation 1 (Battiste
and Wagner, 2000):
r =

K
G2

4tc +
3tc
1+62ht
2
c
1=6
(1)
where tc is the rotational correlation time (at 12.5 or 17
C), K is a collection
of physical constants of 1.23 3 1032 cm6 s2, and uh is the proton Larmor
frequency of 800 MHz 2p rad. Amide PREs with G2 > 10 s
1 and methyl
PREs with G2 > 5 s
1 (provided G2 > uncertainties) were interpreted with Equa-
tion 1. The lower bounds of distance restraints were 10 A˚ below and upper
bounds 3 A˚ above these target distances. For the strongest PREs (at residues
377, 425, and 471), the severe paramagnetic line broadening implies target
distances <13 A˚, and an upper bound of 15 A˚ was assigned to their distance
restraints.
AFM
Following recent work (Fulcher et al., 2014), the wild-type MT1-MMP ectodo-
main was deposited at 100 nM in imaging buffer of 20 mM Tris-HCl (pH 7.5),
10 mM CaCl2, and 150 mM NaCl on freshly cleaved muscovite mica surface
(V-1 grade, SPI Supplies), incubated for 1 min, rinsed three times with 100 ml
of the imaging buffer, and incubated for another 5 min. Images were acquired
at room temperature in the imaging buffer using tapping mode and a Cypher
instrument (Asylum Research). Biolever mini tips (BL-AC40TS, Olympus)
with spring constants 0.06 N m1 were used. Images were recorded with an
estimated tip-sample force <100 pN for minimal distortion of proteins.
Experimental Docking of THP and HPX Domain
Monomeric coordinates from the crystal structure of the HPX domain (Tocho-
wicz et al., 2011) (PDB ID 3c7x) and the homology model of a1(I)772–786 THP
were docked using explicit PRE-based distance restraints and ambiguous dis-
tance restraints to represent residues at the interface (Table 2). The HADDOCK
web server used for the calculations treated the proteins initially as rigid
bodies, subsequently allowed flexibility of residues within 5 A˚ of the interface,
and finally refined in water solvent (de Vries et al., 2007; Dominguez et al.,
2003). PRE-based restraints to the TOAC nitroxide were pointed at NE2 of
the Gln at P4
0 or at CB of the Val at P70 in the THP sequence.
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